60 Degrees Pharmaceuticals (60 Degrees Pharmaceuticals) Total Assets : $8.38 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is 60 Degrees Pharmaceuticals Total Assets?

60 Degrees Pharmaceuticals's Total Assets for the quarter that ended in Mar. 2024 was $8.38 Mil.

During the past 12 months, 60 Degrees Pharmaceuticals's average Total Assets Growth Rate was -27.40% per year. During the past 3 years, the average Total Assets Growth Rate was 32.70% per year.

During the past 4 years, 60 Degrees Pharmaceuticals's highest 3-Year average Total Assets Growth Rate was 32.70%. The lowest was 32.70%. And the median was 32.70%.

Total Assets is connected with ROA %. 60 Degrees Pharmaceuticals's annualized ROA % for the quarter that ended in Mar. 2024 was 21.28%. Total Assets is also linked to Revenue through Asset Turnover. 60 Degrees Pharmaceuticals's Asset Turnover for the quarter that ended in Mar. 2024 was 0.01.

60 Degrees Pharmaceuticals Total Assets Historical Data

The historical data trend for 60 Degrees Pharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

60 Degrees Pharmaceuticals Total Assets Chart

60 Degrees Pharmaceuticals Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Total Assets

2.61

1.39

1.30

7.78

60 Degrees Pharmaceuticals Quarterly Data
	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial							7.59	7.36	9.15	7.78	8.38

60 Degrees Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

60 Degrees Pharmaceuticals's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	4.798	+	2.986
	=	7.78

60 Degrees Pharmaceuticals's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	7.125	+	1.254
	=	8.38

60 Degrees Pharmaceuticals (NAS:SXTPW) Total Assets Explanation

Total Assets is connected with ROA %.

60 Degrees Pharmaceuticals's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	1.72	/	( (7.784	+	8.379)	/ 2 )
	=	1.72	/	8.0815
	=	21.28 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

60 Degrees Pharmaceuticals's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	0.116	/	( (7.784	+	8.379)	/ 2 )
=	0.116	/	8.0815
=	0.01

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

60 Degrees Pharmaceuticals Total Assets Related Terms

Thank you for viewing the detailed overview of 60 Degrees Pharmaceuticals's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

60 Degrees Pharmaceuticals (60 Degrees Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 60 Degrees Pharmaceuticals Inc (NAS:SXTPW) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

SXTP:USA

Address

1025 Connecticut Avenue NW, Suite 1000, Washington, D.C, WA, USA, 20036

Website

https://www.60degreespharma.com

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases through Arakoda and Celgosivir.